Alembic Pharma falls 5% after board nod to Rs 1,150-cr impairment charges
Shares of Alembic Pharma hit a fresh 52-week low after the company’s board approved Rs 1,150 crore impairment charges for three manufacturing facilities in Gujarat.
Latest News from Moneycontrol.com